: The company, which filed to go public in December, said that its net loss for 2014 increased to $14 million from $11.8 million in 2013.
Elaine Mardis, co-director of the Genome Institute at Washington University in St. Louis, discussed genomic testing for cancer in both clinical research and diagnosis.
Restarting the trial will require the company to raise additional funds before its money runs out this summer.
The drug combines an RNAi payload with an agent designed to stimulate a patient's immune system against their tumors.
Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.